Atreca Inc (NASDAQ:BCEL)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BCEL

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BCEL

  • Market Cap$502.250m
  • SymbolNASDAQ:BCEL
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS04965G1094

Company Profile

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Latest BCEL news

Currently there for this company. Visit our news hub for other news .